Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMOPP in Infants or Young Children With PNET or High-Grade Astrocytoma
NCT00002463Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 1989
- Primary completion
- Jan 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in primitive neuroectodermal tumor (PNET), high-grade astrocytoma, sponsored by University of Texas MD Anderson Cancer Center. Started Feb 1989; status: completed.
02
Drugs
methotrexate
03
Conditions
primitive neuroectodermal tumor (PNET)high-grade astrocytoma
Beyond the preview
Go deeper on NCT00002463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002463.